Home
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

112 public trials 49 recruiting studies

Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Recruiting

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

NCT06941129

Conditions: ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

NCT07150000

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +55 more
Locations: University Hospital, Bonn Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

NCT06828042

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +32 more
Locations: Peking University Third Hospital Beijing, China

View Trial Details

Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT06980597

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Beijing Boren Hospital Beijing, China

Beijing GoBroad Hospital Beijing, China

View Trial Details

Recruiting

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

NCT06611696

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +18 more
Locations: Fujita Health University Hospital Toyoake, Aichi-ken, Japan

Asahi General Hospital Asahi, Chiba, Japan

Chiba Aoba Municipal Hospital Chiba, Japan

Chiba University Chiba, Japan

View all 22 locations

View Trial Details

Recruiting

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

NCT06685042

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +20 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Lazio, Italy

View Trial Details

Recruiting

AYLo - AutoimmunitY and Loss of y

NCT06696027

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +61 more
Locations: Department of Rheumatology Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Early-access Avacopan in Real-world ANCA-associated Vasculitis

NCT06794827

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Related conditions